BRIMONIDINE TARTRATE 0.2%w/v IP + TIMOLOL MALEATE 0.5%w/v IP + BENZALKONIUM CHLO...

A fixed-combination ophthalmic drug preparation that is effective in lowering intraocular pressure in patients with ocular hypertension and glaucoma. (Santiago, 2020) An antiglaucoma agent that provides improved control of intraocular pressure. Reduces the production of fluid in the eye and decreases elevated intraocular pressure. (Frampton, 2006) An effective and convenient intraocular pressure-lowering therapy for patients with ocular hypertension or glaucoma. (Mark B Sherwood, 2006) Offers better control of intraocular pressure in cases of ocular hypertension and glaucoma with better patient compliance. (Dimitris Papaconstantinou, 2009) A promising alternative for patients who do not achieve adequate intraocular pressure control while treating with a monotherapeutic agent. (M Călugăru, 2011) An advantageous agent over dorzolamide/timolol with respect to ocular tolerability and comfort. (Frampton, 2006) A superior agent to monotherapy using either timolol or brimonidine in intraocular pressure reduction as well as in reducing fluctuations in intraocular pressure. (Joon Mo Kim T.-W. K.-W.-Y., 2021) Provides sustained intraocular pressure lowering superior to monotherapy with either brimonidine or timolol. (Mark B Sherwood, 2006)